4//SEC Filing
Ng George K 4
Accession 0000897069-24-000229
CIK 0001533743other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:37 PM ET
Size
5.1 KB
Accession
0000897069-24-000229
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-01-30$2.70/sh+10,000$27,000→ 20,000 total(indirect: By Trust)
Footnotes (2)
- [F1]Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F2]Reflects that shares previously reported as directly held by the reporting person were held in a trust.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001638744
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:37 PM ET
- Size
- 5.1 KB